Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Abroad (travel likely)RecruitingPHASE1

Conditions

NF1 · Neurofibromatosis · Cutaneous Neurofibroma · Neurofibroma · Von Recklinghausen Disease · Neurofibromas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Joshua M Roberts, PhD) · jrbrts004@gmail.com · 609-876-9334

Study leads

Carlos Romo, MD
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

NF1 Mutation · Neurofibroma Plexiform · Neurofibroma, Plexiform

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · St Leonards, Australia

Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

Neurofibromatosis Type 1 · Neurofibroma

Abroad (travel likely)Recruiting

Bethesda, United States

Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

Neurofibroma · Neurofibroma, Plexiform

Abroad (travel likely)Recruiting

Lyon, France

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Neurofibromatosis 1 · Plexiform Neurofibromas

Abroad (travel likely)Recruiting

Washington D.C., United States · Chicago, United States